Withdrawal of Albuterol Inhalers Containing Chlorofluorocarbon PropellantsCurrent Concepts:

Abstract

In 2005, the FDA ruled that the sale of CFC albuterol metered-dose inhalers would be prohibited in the US after 2008. Market forces, particularly the limited availability of CFCs, may lead to an earlier transition to HFA albuterol inhalers. Health care providers should understand the reasons for this change and be informed about how these inhalers compare with CFC albuterol inhalers.